Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trialHuabin Hu, Yanhong Deng, Liang Kang et al.|The Lancet. Gastroenterology & hepatology|2021Cited by 304
Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal CancerXuezhi Zhou, Jie Tian, Yongju Yi et al.|Annals of Surgical Oncology|2019Cited by 113
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL TrialHuabin Hu, Yanhong Deng, Jianwei Zhang et al.|Journal of Clinical Oncology|2024Cited by 76
Radiomics-Based Preoperative Prediction of Lymph Node Status Following Neoadjuvant Therapy in Locally Advanced Rectal CancerXuezhi Zhou, Jie Tian, Kai Sun et al.|Frontiers in Oncology|2020Cited by 58
CT-based deep learning model for the prediction of DNA mismatch repair deficient colorectal cancer: a diagnostic studyWuteng Cao, Yanhong Deng, Huabin Hu et al.|Journal of Translational Medicine|2023Cited by 16